Your trusted adviser for R&D Tax Credits, Creative Tax Relief, and R&D Grants
The Grants team at Myriad Associates are proud to announce that they have secured over €30m from the Disruptive Technologies Innovation Fund (DTIF).
Run by the Department of Business, Enterprise and Innovation with administrative support from Enterprise Ireland, the DTIF is a €500 million fund that was established in 2018 under Project Ireland 2040.
And, out of the 29 projects that have so far secured third-round funding from the DTIF, Myriad Associates have recently secured five of them.
From breakthrough cancer treatments to revolutionary heart valve replacements, these five l projects are expected to transform current medical procedures and drastically improve patient outcomes.
The Myriad Associates Grants team, led by Marc Greatrex, worked closely with these five clients to understand the key objectives and the various intricacies and complexities surrounding each project. This comprehensive knowledge, combined with over three years of experience working with the Department of Business, Enterprise and Innovation to submit DTIF grant applications, meant the team were able to secure the funding needed to help push these five critical projects forwards.
“This week we learned we were successful in our application for the Disruptive Technologies Innovation Fund. Myriad Associates have been instrumental in this success. They’re easy to work with, very responsive and have built up a wealth of knowledge as to what makes a successful application. I would highly recommend Myriad Associates for anyone looking to secure grant funding.”
Susan O'Coinne, Chief Financial Officer at ProVerum Medical
This success follows an outstanding track record for the Myriad Associates Grants team. To date, they’ve raised over €74m of DTIF round-three funding for 11 different projects, including ONK Therapeutics which got €4.3m over three years.
“As a team, we are so proud to have the opportunity to work with such great companies and people. Particularly those graduating from BioInnovate which consistently goes from strength to strength. DTIF is a cornerstone funding scheme in Ireland, looking forward to seeing what round 4 holds...”
Marc Greatrex, Director of the Grants Division at Myriad Associates
Who knows, perhaps in round four, we can hit the €100m mark? It’s a challenge we’re readily accepting!
If you have any questions on Grant Funding, R&D Tax Credits or general innovation funding, please do send us a message using our contact page or call 0207 118 6045.
Explore how Budget 2024 boosts innovative UK businesses with new funding, tax incentives, and support for growth. Find out which sectors will benefit most.
The specialist R&D tax credit team at Myriad has once again been successful in its Client’s appeal to the First-Tier Tax Tribunal. Read our latest article to learn more.
UK registered organisations can apply for a share of up to £25 million for game-changing and commercially viable R&D innovations that can significantly impact the UK economy.
Please contact us to discuss how working with Myriad can maximise and secure R&D funding opportunities for your business.
Contact us
hello@myriadassociates.com